Freeline Therapeutics (FRLN)

AI Score

Unlock

6.49

0.01 (0.15%)

At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q2 2019	Q1 2019	Q2 2018	Q1 2018
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Jun 30, 2019	Mar 31, 2019	Jun 30, 2018	Mar 31, 2018
PE Ratio	-0.39	-0.17	6.36	-0.34	-0.76	-0.58	-0.45	-0.51	-0.99	-1.82	-3.14	-4.3	-5.43	-9.32	-1.71	n/a	-106.94	-106.94	-173.21	-173.21
PEG Ratio	0.02	0.00	-0.06	-0.01	0.02	0.01	0.01	-0.04	0.04	-0.13	0.41	-0.09	-0.11	0.11	n/a	n/a	n/a	n/a	n/a	n/a
PS Ratio	3.75K	18.16	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	0.62	0.27	0.53	0.59	0.66	0.63	0.40	0.59	0.80	1.57	2.00	2.62	n/a	5.19	n/a	n/a	n/a	n/a	n/a	n/a
P/FCF Ratio	-2.16	-0.64	-1.57	-1.3	-2.62	-3.3	-1.76	-3.95	-5.15	-8.62	-12.01	-18.72	-17.38	-47.27	-6.17	n/a	-416.65	-416.65	-781.09	-781.09
P/OCF Ratio	-2.16	-0.65	-1.61	-1.55	-3	-3.38	-1.8	-4.09	-5.37	-8.72	-12.81	-19.7	-17.5	-48.28	-6.36	n/a	-440.72	-440.72	-894.71	-894.71
OCF/S Ratio	-1.73K	-28	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.13	0.11	0.10	0.11	0.17	0.64	0.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Quick Ratio	1.90	2.40	2.64	1.61	3.13	3.60	4.66	5.89	8.72	12.11	14.03	13.56	n/a	5.96	n/a	7.09	n/a	n/a	n/a	n/a
Current Ratio	1.95	2.45	2.81	2.18	3.31	3.68	4.82	6.20	8.82	12.21	14.13	13.72	n/a	6.05	n/a	7.16	n/a	n/a	n/a	n/a
Asset Turnover	0.00	0.01	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	0.51	-3.11	-79.42	-107.14	26.23	403.92	-415.28	n/a	n/a	576.05	-519.32	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-0.4	-0.38	0.02	-0.44	-0.22	-0.27	-0.23	-0.29	-0.2	-0.21	-0.16	-0.15	n/a	-0.14	n/a	n/a	n/a	n/a	n/a	n/a
Return on Assets	-0.25	-0.26	0.01	-0.27	-0.15	-0.15	-0.14	-0.25	-0.18	-0.2	-0.15	-0.14	n/a	-0.12	n/a	n/a	n/a	n/a	n/a	n/a
Return on Invested Capital	-0.36	-0.33	-0.29	-0.34	-0.29	-0.18	-0.16	-0.29	-0.23	-0.21	-0.15	-0.13	n/a	-0.17	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	-75.75	0.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	-2.42K	-25.95	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	-2.41K	-25.94	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	-2.45K	-25.37	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	-2.31K	-31	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a